The Indian Pharmacopoeia Commission has issued a drug safety alert regarding amlodipine and acetazolamide, highlighting potential adverse reactions. Healthcare professionals are advised to monitor for adverse drug reactions, while patients should be vigilant for any symptoms. Companies may be required to include warnings in drug packaging.
Epic Pharma Llc`s Generic Acetazolamide Receives Approval in the U.S
Aarkish's Generic Acetazolamide Receives Receives Approval in the U.S.
Zydus' Generic Acetazolamide Receives Approval in the U.S.
Rubicon's Generic Acetazolamide Receives Approval In the US
Micro Labs Ltd India's Generic Acetazolamide Receives Approval In US
Breckenridge Pharmaceutical`s Generic Acetazolamide Receives Approval In US
The formulations include 5-aminosalicylic acid, abacavir (A) + lamivudine (B), acetazolamide, acetylsalicylic acid, acyclovir, allopurinol tablet, alprostadil, alteplase, amiodarone tablet, amlodipine tablet, amoxicillin capsule, amoxicillin (A) + clavulanic acid (B), amphotericin B (Lipid), anti-rabies immunoglobulin injection, artemether (A) + lumefantrine (B), ringer lactate injection 100 ml, 250 ml, 500 ml and 1000 ml among others.
Novitium Pharma`s GenericAcetazolamide Receives Approval in US
Eywa Pharma Generic Acetazolamide Receives Approval in US